Research article summary (published 30 May 2009):

A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level.

Full Abstract

A mathematical model is developed for simulating anabolic behaviour of bone affected by Parathyroid Hormone (PTH) in this paper. The model incorporates a new understanding on the interaction of PTH and other factors with the RANK-RANKL-OPG pathway into bone remodelling, which is able to simulate anabolic actions of bone induced by PTH at cellular level. The RANK-RANKL-OPG pathway together with the dual action of TGF-beta, which represent the core of coupling behaviour between osteoblasts and osteoclasts which are two cell types specialising in the maintenance of bone integrity, are widely considered essential for the regulation of bone remodelling at cellular level. Moreover, the anabolic effect of PTH on bone remodelling (mainly causing bone gain) is significant for therapies of bone disease such as osteoporosis. Although the Food and Drug Administration of United States has approved PTH as an anabolic treatment for osteoporosis, the corresponding underlying mechanism of bone anabolism remains elusive. The proposed mathematical model provides a detailed biological description of bone remodelling using the latest experimental findings and can explain the mechanism of bone anabolic action by PTH that is administered intermittently as well as catabolic effect when applied continuously. The development of such a model provides a rational basis for developing more biologically extensive models that may support the design of optimal dosing strategies for different therapies such as PTH-based anti-osteoporosis treatments.

Author information

Author/s: Wang, Yanan (Y); Qin, Qing-Hua (QH); Kalyanasundaram, Shankar (S);

Affiliation: Department of Engineering, Australian National University, Canberra, ACT 0200, Australia.

Journal and publication information

Publication Type: Journal Article

Journal: Molecular & cellular biomechanics : MCB (Mol Cell Biomech), published in United States. (Language: eng)

Reference: 2009-Jun; vol 6 (issue 2) : pp 101-12

Dates: Created 2009/06/04; Completed 2009/06/23;

PMID: 19496258, status: MEDLINE (last retrieval date: 6/23/2009, IMS Date: 23 Jun 2009 00:00:00)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Algorithms Animals Bone Remodeling - drug effects; physiology Bone and Bones - cytology; drug effects; metabolism Computer Simulation Drug Administration Schedule Humans Models, Biological

Osteoblasts - cytology; drug effects; metabolism Osteoprotegerin - metabolism Parathyroid Hormone - administration & dosage; metabolism Protein Binding RANK Ligand - metabolism Receptor Activator of Nuclear Factor-kappa B - metabolism Signal Transduction Transforming Growth Factor beta - metabolism

Associated Chemicals: Osteoprotegerin (0) ; Parathyroid Hormone (0) ; RANK Ligand (0) ; Receptor Activator of Nuclear Factor-kappa B (0) ; Transforming Growth Factor beta (0)

Related articles

This article has not been indexed for related articles as yet, however you can still use the live related article search links below.

See 100+ related articles.

See a large map of 100+ related articles.